These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 83274)

  • 1. Evidence against the presence of "inhibitors" in coumarin treated patients.
    Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(4):523-9. PubMed ID: 83274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital bleeding disorders of the vitamin K-dependent clotting factors.
    Girolami A; Scandellari R; Scapin M; Vettore S
    Vitam Horm; 2008; 78():281-374. PubMed ID: 18374200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients.
    Xi M; Béguin S; Hemker HC
    Thromb Haemost; 1989 Sep; 62(2):788-91. PubMed ID: 2814925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quick's time and derived times in the study of the extrinsic course of the coagulation process. The PIVKA (protein induced by vitamin K absence or antagonists) in states of chronic disseminated intravascular coagulation].
    Moscarella S; Ventimiglia V
    Quad Sclavo Diagn; 1974 Dec; 10(4):463-73. PubMed ID: 4460075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.
    Bertina RM; Westhoek-Kuipers ME; Alderkamp GH
    Thromb Haemost; 1981 Jun; 45(3):237-41. PubMed ID: 7281102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K deficiency amplifies anticoagulation response to ximelagatran: possible implications for direct thrombin inhibitors and their clinical safety.
    Kamali F; Wood P; Ward A
    Ann Hematol; 2009 Feb; 88(2):141-9. PubMed ID: 18716776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent decrease of "inhibition" in the dilution curve system with the increase of anticoagulation. A paradox that is against the presence of inhibitors in coumarin treated patients.
    Girolami A; Fabris F; dal Bo Zanon R; Cappellato G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(5):670-6. PubMed ID: 75136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glass activation-induced decrease or disappearance of normotest-thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex.
    Girolami A; Patrassi G; Fabris F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(2):283-93. PubMed ID: 69593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence against vitamin K deficiency in normal neonates.
    Malia RG; Preston FE; Mitchell VE
    Thromb Haemost; 1980 Dec; 44(3):159-60. PubMed ID: 7466743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coumarin-induced abnormal factor IX: an immunological study in humans.
    Girolami A; Sticchi A; Burul A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(1):117-24. PubMed ID: 77812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional evidence against the presence of inhibitors in vit. K deficiency and in coumarin-treated patients.
    Girolami A; Patrassi GM; Fabris F; Dal Bo Zanon R
    Thromb Haemost; 1981 Apr; 45(2):192. PubMed ID: 7256702
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor X antigen--factor X activity discrepancy in coumarin treated patients. No relationship with dilution curve.
    Girolami A; Cappellato MG; Lazzaro AR; Simioni P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(1):126-33. PubMed ID: 2439413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of oral and intramuscular vitamin K on the factors II, VII, IX, X, and PIVKA II in the infant newborn under 60 days of age].
    Arteaga-Vizcaíno M; Espinoza Holguín M; Torres Guerra E; Diez-Ewald M; Quintero J; Vizcaíno G; Estévez J; Fernández N
    Rev Med Chil; 2001 Oct; 129(10):1121-9. PubMed ID: 11775338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case report. Phenprocoumon (Marcumar, Falithrom) as an unusual reason for coumarin poisoning in a dog].
    Lutze G; Römhild W; Elwert J; Leppelt J; Kutschmann K
    Dtsch Tierarztl Wochenschr; 2003 Jan; 110(1):31-3. PubMed ID: 12596669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitamin K: biochemistry, function, and deficiency. Review].
    Mijares ME; Nagy E; Guerrero B; Arocha-Piñango CL
    Invest Clin; 1998 Sep; 39(3):213-29. PubMed ID: 9780555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin K and human nutrition.
    Suttie JW
    J Am Diet Assoc; 1992 May; 92(5):585-90. PubMed ID: 1573141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital deficiency of vitamin K-dependent coagulation factors and protein C.
    Vicente V; Maia R; Alberca I; Tamagnini GP; Lopez Borrasca A
    Thromb Haemost; 1984 Jul; 51(3):343-6. PubMed ID: 6548583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent coumarin-induced skin necrosis in a patient with an acquired functional protein C deficiency.
    Teepe RG; Broekmans AW; Vermeer BJ; Nienhuis AM; Loeliger EA
    Arch Dermatol; 1986 Dec; 122(12):1408-12. PubMed ID: 3789774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromogenic substrate (S-2222) factor X assays in the follow-up of coumarin treated patients. No advantage over prothrombin time and/or thrombotest.
    Girolami A; Saggin L; Gazzetta R; Saltarin P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):610-6. PubMed ID: 6170557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.